David Eansor
2017
In 2017, David Eansor earned a total compensation of $1.3M as Senior Vice President Biotechnology at Bio-Techne.
Compensation breakdown
| Non-Equity Incentive Plan | $256,210 |
|---|---|
| Option Awards | $487,412 |
| Salary | $430,000 |
| Stock Awards | $162,522 |
| Other | $11,061 |
| Total | $1,347,206 |
Eansor received $487.4K in option awards, accounting for 36% of the total pay in 2017.
Eansor also received $256.2K in non-equity incentive plan, $430K in salary, $162.5K in stock awards and $11.1K in other compensation.
Rankings
In 2017, David Eansor's compensation ranked 7,533rd out of 14,666 executives tracked by ExecPay. In other words, Eansor earned more than 48.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,533 out of 14,666 | 49th |
Division Manufacturing | 2,818 out of 5,772 | 51st |
Major group Chemicals And Allied Products | 914 out of 2,075 | 56th |
Industry group Drugs | 712 out of 1,731 | 59th |
Industry Biological Products, Except Diagnostic Substances | 136 out of 313 | 57th |
Source: SEC filing on September 9, 2019.
Eansor's colleagues
We found three more compensation records of executives who worked with David Eansor at Bio-Techne in 2017.